Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 94, Issue 24, 1997, Pages 13311-13316

  Hamilton, Susan E ^a   Loose, Michael D ^b   Qi, Ming ^a   Levey, Allan I ^c   Hille, Bertil ^a   Mcknight, G Stanley ^a   Idzerda, Rejean L ^a   Nathanson, Neil M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b OBERLIN COLLEGE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; PILOCARPINE; POTASSIUM CHANNEL; RECEPTOR SUBTYPE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; EMBRYO; GENE TARGETING; LEARNING; MEMORY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; RECEPTOR DENSITY; SEIZURE; SYMPATHETIC NERVE CELL;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE SUSCEPTIBILITY; KAINIC ACID; LIGANDS; MICE; MICE, KNOCKOUT; MUSCARINIC ANTAGONISTS; PILOCARPINE; RECEPTORS, MUSCARINIC; SEIZURES;

ANIMALIA;

EID: 0030708762     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.94.24.13311     Document Type: Article

References (44)

1. Messer, W. S., Bohnett, M. & Stibbe, J. (1990) Neurosci. Lett. 116, 184-189.
2. Messer, W. S., Stibbe, J. R. & Bohnett, M. (1991) Brain Res. 564, 66-72.
3. Velaquez-Moctezuma, J., Gillin, J. C. & Shiromani, P. J. (1989) Brain Res. 503, 128-131.
4. Bartolini, A., Ghelardini, C., Fantetti, L., Malcangio, M., Malmberg-Aiello, P. & Giotti, A. (1992) Br. J. Pharmacol. 105, 77-82.
5. Turski, L., Ikonomidou, C., Turski, W. A., Bortolotto, A. A. & Cavalheiro, E. A. (1989) Synapse 3, 154-171.
6. Hammer, R. & Giachetti, A. (1982) Life Sci. 31, 2991-2999.
7. Bonner, T. I., Buckley, N. J., Young, A. C. & Brann, M. R. (1987) Science 237, 527-532.
8. Bonner, T. I., Young, A. C., Brann, M. R. & Buckley, N. J. (1988) Neuron 1, 403-410.
9. Hulme, E. C., Birdsall, N. J. M. & Buckley, N. J. (1990) Annu. Rev. Pharmacol. Toxicol. 30, 633-673.
10. Nathanson, N. M. (1987) Annu. Rev. Neurosci. 10, 195-236.
11. Caulfield, M. P. (1993) Pharmacol. Ther. 58, 319-379.
12. Wess, J. (1996) Crit. Rev. Neurobiol. 10, 69-99.
13. Adams, P. R., Brown, D. A. & Constanti, A. (1982) J. Physiol. 332, 223-262.
14. Cole, A. E. & Nicoll, R. A. (1984) Brain Res. 305, 283-290.
15. Marrion, N. V. (1997) Annu. Rev. Physiol. 59, 483-504.
16. Marrion, N. V., Smart, T. G., Marsh, S. J. & Brown, D. A. (1989) Br. J. Pharmacol. 98, 557-573.
17. Bernheim, L., Mathie, A. & Hille, B. (1992) Proc. Natl. Acad. Sci. USA 89, 9544-9548.
18. Dorje, F., Levey, A. I. & Brann, M. R. (1991) Mol. Pharmacol. 40, 459-462.
19. Mello, L. M., Cavalheiro, E. A., Tan, A. M., Kupfer, W. R., Pretorius, J. K., Babb, T. L. & Finch, D. M. (1993) Epilepsia 34, 985-995.
20. Turski, W. A., Cavalheiro, E. A., Bortolotto, Z. A., Mello, L. M., Schwarz, M. & Turski, L. (1984) Brain Res. 321, 237-253.
21. Wasterlain, C. G. & Jonec, V. (1983) Brain Res. 271, 311-323.
22. Cruickshank, J. W., Brudzynski, S. M. & McLachlan, R. S. (1994) Brain Res. 643, 125-129.
23. Maslanski, J. A., Powelt, R., Deirmengiant, C. & Patelt, J. (1994) Neurosci. Lett. 168, 225-228.
24. Gale, K. (1993) in Epilepsy: Models, Mechanisms, and Concepts, ed. Schwartzkroin, P. A. (Cambridge Univ. Press, Cambridge), pp. 48-93.
25. Solberg, Y. & Belkin, M. (1997) Trends Pharmacol. 18, 183-185.
26. Shapiro, R. A., Scherer, N. M., Habecker, B. A., Subers, E. M. & Nathanson, N. M. (1988) J. Biol. Chem. 263, 18397-18403.
27. Brandon, E. P., Gerhold, K. A., Qi, M., McKnight, G. S. & Idzerda, R. L. (1995) Recent Prog. Horm. Res. 50, 403-408.
28. Levey, A. I., Kitt, C. A., Simonds, W. F., Price, D. L. & Brann, M. R. (1991) J. Neurosci. 11, 3218-3226.
29. McKinnon, L. A. & Nathanson, N. M. (1995) J. Biol. Chem. 270, 20636-20642.
30. Luetje, C. W., Brumwell, C., Morman, M. G., Peterson, G. L., Schimerlik, M. I. & Nathanson, N. M. (1987) Biochemistry 24, 6892-6896.
31. Nathanson, N. M. (1983) J. Neurochem. 41, 1545-1549.
32. Bernheim, L., Beech, D. J. & Hille, B. (1991) Neuron 6, 859-867.
33. Shapiro, M. S. & Hille, B. (1993) Neuron 10, 11-20.
34. Starr, M. S. & Starr, B. S. (1994) Pharmol. Biochem. Behav. 47, 127-131.
35. Hosford, D. A. & McNamara, J. O. (1988) Brain Res. 462, 205-210.
36. Morrison, R. S., Wenzel, H. J., Kinoshita, Y., Robbins, C. A., Donehower, L. A. & Schwarzkroin, P. A. (1996) J. Neurosci. 16, 1337-1345.
37. Constanti, A. & Brown, D. A. (1981) Neurosci. Lett. 24, 289-294.
38. Lothman, E. W. & Collins, R. C. (1981) Brain Res. 218, 299-318.
39. Brown, E., Kendall, D. A. & Nakorski, S. R. (1984) J. Neurochem. 42, 1379-1387.
40. McCormick, D. A. & Prince, D. A. (1985) Proc. Natl. Acad. Sci. USA 82, 6344-6348.
41. Harvey, J., Balasubramaniam, R. & Collingridge, G. L. (1993) Neurosci. Lett. 162, 165-168.
42. Liu, C. & Gillette, M. U. (1996) J. Neurosci. 16, 744-751.
43. Gu, Q. & Singer, W. (1993) Eur. J. Neurosci. 5, 475-485.
44. Polidori, C., Massi, M., Lambrecht, G., Mutschler, E., Tacke, R. & Melchiorre, C. (1990) Eur. J. Pharmacol. 179, 159-165.